litlas
Log inCreate account

Michael R. Liebowitz

Active 1982–2025

78
Papers
20,888
Citations
75
h-index
78
i10-index

Citations

Citations per year for Michael R. Liebowitz1984: 4 citations1985: 6 citations1986: 19 citations1987: 10 citations1988: 23 citations1989: 31 citations1990: 36 citations1991: 24 citations1992: 45 citations1993: 42 citations1994: 55 citations1995: 47 citations1996: 27 citations1997: 63 citations1998: 74 citations1999: 73 citations2000: 104 citations2001: 101 citations2002: 120 citations2003: 105 citations2004: 122 citations2005: 116 citations2006: 87 citations2007: 104 citations2008: 149 citations2009: 115 citations2010: 139 citations2011: 119 citations2012: 89 citations2013: 103 citations2014: 108 citations2015: 102 citations2016: 85 citations2017: 65 citations2018: 54 citations2019: 190 citations2020: 206 citations2021: 221 citations2022: 144 citations2023: 85 citations2024: 161 citations2025: 84 citations2026: 13 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,411 citing papers, 37.7% of this breakdownUnited Kingdom: 306 citing papers, 8.2% of this breakdownGermany: 231 citing papers, 6.2% of this breakdownCanada: 218 citing papers, 5.8% of this breakdownNetherlands: 145 citing papers, 3.9% of this breakdownItaly: 131 citing papers, 3.5% of this breakdownAustralia: 123 citing papers, 3.3% of this breakdownChina: 113 citing papers, 3% of this breakdownSweden: 82 citing papers, 2.2% of this breakdownIsrael: 69 citing papers, 1.8% of this breakdownFrance: 65 citing papers, 1.7% of this breakdownSwitzerland: 61 citing papers, 1.6% of this breakdown
0%37.7%Other 21.1%

Institutions

Fields

  • Psychology51.7%
  • Medicine26.9%
  • Neuroscience14.3%
  • Social Sciences1.7%
  • Computer Science1.7%
  • Biochemistry, Genetics and Molecular Biology1.3%
  • Other2.4%

Topics

  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes13.2%
  • Treatment of Major Depression6.9%
  • Obsessive-Compulsive Spectrum Disorders5.4%
  • Child and Adolescent Psychosocial and Emotional Development4.4%
  • Neurotransmitter Receptor Influence on Behavior3.8%
  • Mental Health Research Topics3.1%
  • Other63.2%

Coauthors

All papers

Open in search
  1. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

    Authors: Maggie Fedgchin, Madhukar H. Trivedi, Ella Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael R. Liebowitz, Arun Ravindran, Raphaël Gaillard, Hans van den Ameele, Sheldon Preskorn, Husseini K. Manji, David Hough, Wayne C. Drevets, Jaskaran Singh - The International Journal of Neuropsychopharmacology 2019 cited by 590

  2. Psychometric properties of the Liebowitz Social Anxiety Scale

    Authors: Richard G. Heimberg, Kelly J. Horner, Harlan R. Juster, Steven A. Safren, Elissa J. Brown, Franklin R. Schneier, Michael R. Liebowitz - Psychological Medicine 1999 cited by 963

  3. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale

    Authors: Douglas S. Mennin, David M. Fresco, Richard G. Heimberg, Franklin R. Schneier, Sharon Davies, Michael R. Liebowitz - Journal of Anxiety Disorders 2002 cited by 510

  4. The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats

    Authors: David M. Fresco, Meredith E. Coles, Richard G. Heimberg, Michael R. Liebowitz, Sarah Hami, Murray B. Stein, Deborah Goetz - Psychological Medicine 2001 cited by 870

  5. The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

    Authors: Mark E. Schmidt, Michael R. Liebowitz, Murray B. Stein, Jennifer Grunfeld, Ilse Van Hove, W. Kyle Simmons, Peter van der Ark, James A. Palmer, Ziad S. Saad, Darrel J. Pemberton, Luc Van Nueten, Wayne C. Drevets - Neuropsychopharmacology 2020 cited by 101

  6. Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

    Authors: Edna B. Foa, Michael R. Liebowitz, Michael J. Kozak, Sharon Davies, Rafael Campeas, Martin E. Franklin, Jonathan D. Huppert, Kevin Kjernisted, Vivienne C. Rowan, Andrew B. Schmidt, H. Blair Simpson, Xin Tu - American Journal of Psychiatry 2004 cited by 1,041

  7. Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

    Authors: Lenard A. Adler, Julie Adams, Jessica Madera‐McDonough, Eva Kohegyi, Mary Hobart, Denise Chang, Mark Angelicola, Robert D. McQuade, Michael R. Liebowitz - Journal of Clinical Psychopharmacology 2022 cited by 43

  8. Assessment of anxiety in social interaction and being observed by others: The social interaction anxiety scale and the Social Phobia Scale

    Authors: Richard G. Heimberg, Gregory P. Mueller, Craig S. Holt, Debra A. Hope, Michael R. Liebowitz - Behavior Therapy 1992 cited by 750

  9. Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale

    Authors: Nina K. Rytwinski, David M. Fresco, Richard G. Heimberg, Meredith E. Coles, Michael R. Liebowitz, Shadha Hami Cissell, Murray B. Stein, Stefan G. Hofmann - Depression and Anxiety 2008 cited by 430

  10. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder

    Authors: Lenard A. Adler, Michael R. Liebowitz, William G. Kronenberger, Meihua Qiao, Richard L. Rubin, Millie Hollandbeck, Ahmed Deldar, Kory Schuh, Todd M. Durell - Depression and Anxiety 2009 cited by 174

  11. Managing dissociative symptoms following the use of esketamine nasal spray: a case report

    Authors: Sophia Pereira, Emily Brennan, Anjali Patel, Melissa Moran, Jenny Wallier, Michael R. Liebowitz - International Clinical Psychopharmacology 2020 cited by 28

  12. An Investigation of Gender Differences in Social Phobia

    Authors: Cynthia L. Turk, Richard G. Heimberg, Susan M. Orsillo, Craig S. Holt, Andrea Gitow, Linda L. Street, Franklin R. Schneier, Michael R. Liebowitz - Journal of Anxiety Disorders 1998 cited by 185

  13. Fear and avoidance of eye contact in social anxiety disorder

    Authors: Franklin R. Schneier, Thomas L. Rodebaugh, Carlos Blanco, Hillary Lewin, Michael R. Liebowitz - Comprehensive Psychiatry 2010 cited by 160

  14. The OCI-R: Validation of the subscales in a clinical sample

    Authors: Jonathan D. Huppert, Michael Walther, Greg Hajcak, Elna Yadin, Edna B. Foa, H. Blair Simpson, Michael R. Liebowitz - Journal of Anxiety Disorders 2006 cited by 328

  15. Response Versus Remission in Obsessive-Compulsive Disorder

    Authors: H. Blair Simpson, Jonathan D. Huppert, Eva Petkova, Edna B. Foa, Michael R. Liebowitz - The Journal of Clinical Psychiatry 2006 cited by 245

  16. A Placebo-Controlled Trial of Phenelzine, Cognitive Behavioral Group Therapy, and Their Combination for Social Anxiety Disorder

    Authors: Carlos Blanco, Richard G. Heimberg, Franklin R. Schneier, David M. Fresco, Henian Chen, Cynthia L. Turk, Donna Vermes, Brigette A. Erwin, Andrew B. Schmidt, Harlan R. Juster, Raphael Campeas, Michael R. Liebowitz - Archives of General Psychiatry 2010 cited by 207

  17. Empirical Validation and Psychometric Evaluation of the Brief Fear of Negative Evaluation Scale in Patients With Social Anxiety Disorder.

    Authors: Justin W. Weeks, Richard G. Heimberg, David M. Fresco, Trevor Hart, Cynthia L. Turk, Franklin R. Schneier, Michael R. Liebowitz - Psychological Assessment 2005 cited by 558

  18. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

    Authors: James T. Hartford, Susan G. Kornstein, Michael R. Liebowitz, Teresa A. Pigott, James Russell, Michael J. Detke, Daniel Walker, Susan Ball, Eduardo Dunayevich, Jeff Dinkel, J. Erickson - International Clinical Psychopharmacology 2007 cited by 287

  19. Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder

    Authors: H. Blair Simpson, Edna B. Foa, Michael R. Liebowitz, Jonathan D. Huppert, Shawn P. Cahill, Michael J. Maher, Carmen P. McLean, James F. Bender, Sue M. Marcus, Monnica T. Williams, James Weaver, Donna Vermes, Page E. Van Meter, Carolyn I. Rodríguez, Mark B. Powers, Anthony Pinto, Patricia Imms, Chang-Gyu Hahn, Raphael Campeas - JAMA Psychiatry 2013 cited by 242

  20. Maternal mental representations of the child in an inner-city clinical sample: Violence-related posttraumatic stress and reflective functioning

    Authors: Daniel S. Schechter, Tammy Coots, Charles H. Zeanah, Mark Davies, Susan Coates, Kimberly A. Trabka, Randall D. Marshall, Michael R. Liebowitz, Michael M. Myers - Attachment & Human Development 2005 cited by 211

  21. Dopamine transporters, D2receptors, and dopamine release in generalized social anxiety disorder

    Authors: Franklin R. Schneier, Anissa Abi‐Dargham, Diana Martínez, Mark Slifstein, Dah‐Ren Hwang, Michael R. Liebowitz, Marc Laruelle - Depression and Anxiety 2009 cited by 99

  22. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults

    Authors: Randall D. Marshall, Roberto Lewis‐Fernández, Carlos Blanco, H. Blair Simpson, Shu‐Hsing Lin, Donna Vermes, Wendy Garcia, Franklin R. Schneier, Yuval Neria, Arturo Sánchez-Lacay, Michael R. Liebowitz - Depression and Anxiety 2006 cited by 97

  23. Generalizability of Clinical Trial Results for Major Depression to Community Samples

    Authors: Carlos Blanco, Mark Olfson, Renée D. Goodwin, Elizabeth L. Ogburn, Michael R. Liebowitz, Edward V. Nunes, Deborah S. Hasin - The Journal of Clinical Psychiatry 2008 cited by 78

  24. Social Phobia

    Authors: Michael R. Liebowitz - Archives of General Psychiatry 1985 cited by 2,234